Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Multimodal AI Agent for Ophthalmic Clinical Decision Support
Sponsor: The Hong Kong Polytechnic University
Summary
This study is a multicenter randomized controlled trial evaluating the effectiveness and safety of EyeAgent, a multimodal artificial intelligence (AI) agent designed to assist ophthalmologists in clinical decision-making. Participants will be recruited from ophthalmology clinics and hospitals in Hong Kong and mainland China. The AI agent acts as a digital co-pilot, analyzing patient images and clinical history to provide diagnostic and management recommendations. The trial aims to determine whether the use of the AI agent improves diagnostic accuracy, treatment decision-making performance, report generation, workflow efficiency, and user satisfaction compared to standard clinical practice.
Official title: Multicenter Randomized Controlled Trial of a Multimodal AI Agent for Ophthalmology Clinical Decision Support
Key Details
Gender
All
Age Range
6 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2026-03-01
Completion Date
2026-12-31
Last Updated
2026-02-23
Healthy Volunteers
Yes
Interventions
EyeAgent AI system
EyeAgent is a multimodal AI agent assistant for ophthalmology that integrates imaging, electronic health records, and curated clinical knowledge. In this arm, EyeAgent supports clinicians in clinical consultation, including report generation, diagnostic interpretation, and treatment planning.
Locations (1)
The Hong Kong Polytechnic University
Hong Kong, China